GALERA THERAPEUTICS INC
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GRTX and buy or sell other stocks, ETFs, and their options commission-free!About GRTX
Galera Therapeutics, Inc. is a clinical stage biotechnology company, which engages in developing and commercializing a pipeline of novel, proprietary therapeutics for cancer. It is also involved in the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis, and cancer.
CEOJohn Mel Sorensen
CEOJohn Mel Sorensen
Employees3
Employees3
HeadquartersMalvern, Pennsylvania
HeadquartersMalvern, Pennsylvania
Founded2009
Founded2009
Employees3
Employees3
GRTX Key Statistics
Market cap1.91M
Market cap1.91M
Price-Earnings ratio-0.16
Price-Earnings ratio-0.16
Dividend yield—
Dividend yield—
Average volume31.78K
Average volume31.78K
High today$0.0294
High today$0.0294
Low today$0.0201
Low today$0.0201
Open price$0.0201
Open price$0.0201
Volume3.24K
Volume3.24K
52 Week high$0.0598
52 Week high$0.0598
52 Week low$0.0151
52 Week low$0.0151
Stock Snapshot
GALERA THERAPEUTICS INC(GRTX) stock is priced at $0.02, giving the company a market capitalization of 1.91M. It carries a P/E multiple of -0.16.
On 2025-11-23, GALERA THERAPEUTICS INC(GRTX) stock traded between a low of $0.02 and a high of $0.03. Shares are currently priced at $0.02, which is +5.0% above the low and -28.2% below the high.
GALERA THERAPEUTICS INC(GRTX) shares are trading with a volume of 3.24K, against a daily average of 31.78K.
During the past year, GALERA THERAPEUTICS INC(GRTX) stock moved between $0.02 at its lowest and $0.06 at its peak.
During the past year, GALERA THERAPEUTICS INC(GRTX) stock moved between $0.02 at its lowest and $0.06 at its peak.
People also own
Based on the portfolios of people who own GRTX. This list is generated using Robinhood data, and it’s not a recommendation.